NewsBenzinga셀라스 라이프 사이언스, SLS009의 MYC 증폭 췌장암 모델에서의 시너지 및 활성 효과를 입증한 전임상 데이터 발표 셀라스 라이프 사이언스, SLS009의 MYC 증폭 췌장암 모델에서의 시너지 및 활성 효과를 입증한 전임상 데이터 발표 Benzinga 2026.09.25 17:03 (GMT+0) Open on Benzinga Other news Lennar Shares Jumped After Berkshire Hathaway Increased Its Position. How Investors Should View the Move. PYPL Stock Alert: What to Know as PayPal Takeover Rumors Restart Mark Wahlberg is coming to TechCrunch Disrupt 2026, and he wants to talk about your work, not his How to Play VRT Stock as Vertiv Acquires King Environmental Services Ahead of US IPO, British AI neocloud Nscale secures $3.36B in convertible financing Unusual Options Activity in Microsoft Stock Is Already Paying Off (and 3 Other Stocks to Watch)
Lennar Shares Jumped After Berkshire Hathaway Increased Its Position. How Investors Should View the Move.
